In this episode of WCG Talks Trials, join Silvio Galea, chief data and analytics officer, WCG, and Melissa Hutchens, vice president of research and benchmarking, WCG, as they discuss the transformative role of AI in clinical trials. Discover how generative AI and other AI machine learning technologies are enhancing the quality of clinical trials, reducing cycle times, and cutting costs. The episode covers the benefits, barriers, and concerns associated with AI, and explores its applications in drug discovery, trial design, participant recruitment, and more. Tune in to learn about the latest advancements in AI and how they are shaping the future of clinical trials.
AI in Clinical Trials: Unlocking the Potential
Updated on October 30, 2025
Originally published on March 24, 2025

